Guerra Eva - Medical Oncology Department, Hospital Universitario Ramon y Cajal

基本信息

浏览量：23

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 77 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

#928 Subgroup Analysis by Chemotherapy Regimen in the ENGOT-Ov41/GEICO 69-O/ANITA Phase 3 Trial Evaluating Atezolizumab Combined with a Platinum Doublet and Maintenance Niraparib for Late-Relapsing Ovarian Cancer

Florian Heitz,Beatriz Pardo,Renaud Sabatier,Nicoletta Colombo,Stéphanie Henry,Gloria Marquina,Florence Joly,María Quindós,Laura Mansi,Purificación Estévez-García,Jean‐Sébastien Frenel,Eva Guerra,

openalex（2024）

引用0浏览0引用

Anthracyclines-induced Cardiotoxicity in Patients with Early Breast Cancer Carrying Germline BRCA1/2 Mutation: the BRCAN Study

Alfonso Cortés-Salgado,Juan José Serrano,David Cordero Pereda,Miriam Menacho,José Manuel Del Rey, Laura Del Campo-Albendea,Cristina Saavedra,Jesús Chamorro,Diana Rosero,Pilar Sotoca,Carmen Guillén-Ponce,Eva Guerra,

The oncologist (2024)

引用0浏览0WOS引用

Detrimental Effect of an Early Exposure to Antibiotics on the Outcomes of Immunotherapy in a Multi-Tumor Cohort of Patients

Patricia Guerrero,Victor Albarran, Carlos Gonzalez-Merino,Coral Garcia de Quevedo,Pilar Sotoca,Jesus Chamorro,Diana Isabel Rosero, Ana Barrill,Victor Alia,Juan Carlos Calvo,Jaime Moreno,Patricia Perez de Aguado,

ONCOLOGIST（2024）

引用0浏览0WOS引用

A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

Mansoor R Mirza,Antonio González-Martín,Whitney S Graybill,David M O'Malley,Lydia Gaba, Oi Wah Stephanie Yap,Eva M Guerra,Peter G Rose,Jean-François Baurain,Sharad A Ghamande,Hannelore Denys,Emily Prendergast,

Future oncology (London, England)no. 13 (2024): 799-809

引用0浏览0WOS引用

A Plain Language Summary of Publication of the Efficacy and Safety of Individualized Niraparib Dosing Based on Baseline Body Weight and Platelet Count in the PRIMA/ENGOT-OV26/GOG-3012 Trial

Mansoor Raza Mirza,Antonio González-Martín,Whitney Graybill,David M. O’Malley,Lydia Gaba, Oi Wah S. Yap,Eva Guerra,Peter G. Rose,Jean‐François Baurain,Sharad Ghamande,Hannelore Denys,Emily Prendergast,

Future oncologyno. 13 (2024): 799-809

引用0浏览0引用

Role of the Receptor for Advanced Glycation End Products (RAGE) in Blood As a Potential Biomarker for Progression to Olaparib: A Post Hoc Analysis of Patients with Platinum-Resistant Ovarian Cancer (PROC) Treated in the ROLANDO-GEICO 1601 Trial

Jose Alejandro Perez-Fidalgo,Beatriz Tavira, Carlos J. Pena,Eva Guerra, Juan Jose Martinez-Pretel, Yolanda Garcia,Begona Pineda,Maria Iglesias,Maria Hernandez-Sosa,Purificacion Estevez-Garcia,Ana Santaballa,Luis Manso Sanchez,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Bhavana Pothuri,Sileny Han,Dana M. Chase,Florian Heitz,Robert A. Burger,Lydia Gaba,Linda Van Le,Eva Guerra,David Bender,Jacob Korach,Noelle Cloven,Cristina Churruca,

GYNECOLOGIC ONCOLOGY（2024）

引用0浏览0WOS引用

HER2 Expression in a Molecularly Characterized Cohort of Patients with Endometrial Cancer (EC): SPECTRUM Study

Alfonso Cortes Salgado, Esther Moreno, Jose Palacios,Eva Guerra, Laura del Campo-Albendea,Irene Carretero-Barrio, Marta Rosas,Cristina Saavedra Serrano,Maria Gion, Tamara Caniego-Casas,Maria Fernandez-Abad,Elena Lopez Miranda,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

#928 Subgroup analysis by chemotherapy regimen in the ENGOT-Ov41/GEICO 69-O/ANITA phase 3 trial evaluating atezolizumab combined with a platinum doublet and maintenance niraparib for late-relapsing ovarian cancer

Late Breaking Abstracts (2024)

引用0浏览0引用

Safety of Bevacizumab and Olaparib As Frontline Maintenance Therapy in Advanced Ovarian Cancer: Expert Review for Clinical Practice

Ignacio Romero,Eva Guerra,Ainhoa Madariaga,Luis Manso

Frontiers in Oncology（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn